ILLUMINA INC. Products & Brands - Key Offerings and Insights

Products

Category

Product

Brand

Description

Companion Diagnostics (BIO077F)

Praxis Extended RAS Panel CDx Assay (FDA Approved)		It is used to identify colorectal cancer patients suitable for treatment with Vectibix (panitumumab).
CDx version of TruSight Tumor 170 and TruSight Oncology 500 CDx Assay (LDTs)		It is a developed test used as companion diagnostics.
MiSeqDx Instrument		It is an NGS-based instrument used to perform companion diagnostic tests.

This information is available for BCC Research members only.

Already a Member? Sign In Become a Member

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.